by Dr. Andrés Gómez De León, MD
Dr. Amar Kelkar from Dana Farber Cancer Institute presented concepts that should be in the minds of all...
by ASTCT Talks
In this latest episode of ASTCT Talks, Dr. Rahul Banerjee, MD, FACP, sits down with Dr. Amrita Krishnan, MD. They delve into the use of GPRC5D as a target in myeloma therapy, specifically focusing...
by ASTCT Science Highlights
Masetti R, Leardini D, Muratore E, et al. Gut Microbiota Diversity Before Allogeneic Hematopoietic Stem Cell Transplantation as Predictor of Mortality in Children. Blood. 2023; (doi:...
by ASTCT Science Highlights
A single injection of motixafortide + granulocyte colony-stimulating factor (G-CSF) in multiple myeloma (MM) patients undergoing autologous stem cell transplantation mobilized more CD34+...
by Eleanor Mayfield, ELS
Blinatumomab added to the Interfant-06 chemotherapy regimen appeared safe and was highly efficacious in infants with newly diagnosed KMT2A-rearranged acute lymphoblastic leukemia (ALL) compared...
by ASTCT Science Highlights
Minnie SA, Waltner OG, Ensbey KS, et al. TIGIT Inhibition and Lenalidomide Synergistically Promote Anti-Myeloma Immune Responses After Stem Cell Transplantation in Mice. Journal of Clinical...